111 related articles for article (PubMed ID: 3432157)
1. The metabolism of EGYT-475, a new antidepressant agent, in rats.
Guttmann A; Nagy J; Magyar K
Pol J Pharmacol Pharm; 1987; 39(2):123-8. PubMed ID: 3432157
[TBL] [Abstract][Full Text] [Related]
2. Species differences in the in vitro metabolism of EGYT-475, a new antidepressant agent.
Fonyó M; Guttmann A; Magyar K
Pol J Pharmacol Pharm; 1987; 39(2):129-34. PubMed ID: 3432158
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic aspects of the mode of action of EGYT-475, a new antidepressant agent.
Magyar K
Pol J Pharmacol Pharm; 1987; 39(2):107-12. PubMed ID: 3432154
[TBL] [Abstract][Full Text] [Related]
4. New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine.
Staack RF; Fritschi G; Maurer HH
J Mass Spectrom; 2003 Sep; 38(9):971-81. PubMed ID: 14505325
[TBL] [Abstract][Full Text] [Related]
5. [Metabolism of the antidepressant azaphene in rats].
Gortinskaia TV; Siniukhin VN; Ostroumova HG; Rozynov BV; Nyrkova VG
Farmakol Toksikol; 1973; 36(5):673-7. PubMed ID: 4802265
[No Abstract] [Full Text] [Related]
6. Studies on the metabolism and the toxicological analysis of the nootropic drug fipexide in rat urine using gas chromatography-mass spectrometry.
Staack RF; Maurer HH
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 May; 804(2):337-43. PubMed ID: 15081928
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
Prakash C; Kamel A; Gummerus J; Wilner K
Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
[TBL] [Abstract][Full Text] [Related]
8. New designer drug 1-(3,4-methylenedioxybenzyl) piperazine (MDBP): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.
Staack RF; Maurer HH
J Mass Spectrom; 2004 Mar; 39(3):255-61. PubMed ID: 15039932
[TBL] [Abstract][Full Text] [Related]
9. Comparison of serotonin agonistic and antagonistic activities of a new antidepressant agent Trelibet (EGYT-475) and its metabolite EGYT-2760 on isolated rat fundus.
Malomvölgyi B; Tóthfalusi L; Tekes K; Magyar K
Acta Physiol Hung; 1991; 78(3):201-9. PubMed ID: 1814162
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
11. Studies on the biochemical mode of action of EGYT-475, a new antidepressant.
Tekes K; Tóthfalusi L; Malomvölgyi B; Hermán F; Magyar K
Pol J Pharmacol Pharm; 1987; 39(2):203-11. PubMed ID: 2448760
[TBL] [Abstract][Full Text] [Related]
12. Urinary bivalent sulfur metabolites of phenanthrene excreted by the rat and guinea pig.
Lertratanangkoon K; Horning MG; Middleditch BS; Tsang WS; Griffin GW
Drug Metab Dispos; 1982; 10(6):614-23. PubMed ID: 6130910
[TBL] [Abstract][Full Text] [Related]
13. Excretion and metabolism of flunarizine in rats and dogs.
Meuldermans W; Hendrickx J; Hurkmans R; Swysen E; Woestenborghs R; Lauwers W; Heykants J
Arzneimittelforschung; 1983; 33(8):1142-51. PubMed ID: 6685491
[TBL] [Abstract][Full Text] [Related]
14. [Absorption and organ distribution of the new antidepressant azaphen].
Siniukhin VN
Farmakol Toksikol; 1973; 26(4):409-11. PubMed ID: 4789881
[No Abstract] [Full Text] [Related]
15. Fluvoxamine: metabolic fate in animals.
Ruijten HM; de Bree H; Borst AJ; de Lange N; Scherpenisse PM; Vincent WR; Post LC
Drug Metab Dispos; 1984; 12(1):82-92. PubMed ID: 6141918
[TBL] [Abstract][Full Text] [Related]
16. Analysis of 4-methyl-piperazine-1-carbodithioic acid 3-cyano-3,3-diphenyl-propyl ester hydrochloride and its major metabolites in rat plasma and tissues by LC-MS/MS.
Jiang X; Ling X; Han F; Li R; Cui J
J Sep Sci; 2007 Aug; 30(13):2080-5. PubMed ID: 17638372
[TBL] [Abstract][Full Text] [Related]
17. The effect of EGYT-475 (Trelibet) and its metabolites on the potassium-stimulated 3H-noradrenaline release from cortical slices of rat brain.
Szücks Z; Szentendrei T; Fekete MI
Pol J Pharmacol Pharm; 1987; 39(2):185-93. PubMed ID: 3432167
[TBL] [Abstract][Full Text] [Related]
18. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296
[TBL] [Abstract][Full Text] [Related]
19. Quantitative metabolic fate of propranolol in the dog, rat, and hamster using radiotracer, high performance liquid chromatography, and gas chromatography-mass spectrometry techniques.
Bargar EM; Walle UK; Bai SA; Walle T
Drug Metab Dispos; 1983; 11(3):266-72. PubMed ID: 6135586
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, metabolism, and disposition of the antiinflammatory 3-[2-(4-methylphenyl)-thioethyl]-sydnone-5-14C in the rat.
Pirl JN; Bell CL; Lu MC; Bauer L
Arzneimittelforschung; 1985; 35(3):578-84. PubMed ID: 4039583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
